OL Oncology Letters 1792-1074 1792-1082 D.A. Spandidos 10.3892/ol.2018.7997 OL-0-0-7997 Articles Berberine regulates the microRNA-21-ITGΒ4-PDCD4 axis and inhibits colon cancer viability LüYanfeng 1 HanBingbing 2 YuHualong 1 CuiZhenghua 1 LiZhiwen 1 WangJianxin 1 Department of Anoproctology, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China Microcirculation Laboratory, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China Correspondence to: Dr Jianxin Wang, Department of Anoproctology, The Second Hospital of Shandong University, 247 Beiyuan Street, Jinan, Shandong 250033, P.R. China, E-mail: jian_xinwang@yeah.net 04 2018 08 02 2018 15 4 5971 5976 26112015 16052017 Copyright © 2018, Spandidos Publications 2018

Berberine is sourced from multiple medicinal herb resources and is easy to extract. With the advantages of low price, safety and convenience, berberine may have potential for wide clinical use. The present study aimed to investigate whether berberine inhibited the viability of colon cancer and whether it regulated the three-gene network microRNA (miR)-21-integrin β4 (ITGβ4)-programmed cell death 4 (PDCD4). It was demonstrated that berberine treatment suppressed colon cancer cell viability, and induced apoptosis and activated caspase-3 activity in the human colon carcinoma HCT116 cell line. Berberine inhibited miR-21 expression and promoted ITGβ4 and PDCD4 protein expression in the HCT116 cell line. Overexpression of miR-21 reduced the anti-cancer effects of berberine on cell viability, apoptosis rate and caspase-3 activity of the HCT116 cell line. However, it was revealed that the overexpression of miR-21 also suppressed ITGβ4 and PDCD4 protein expression in the HCT116 cell line. In conclusion, miR-21, ITGβ4 and PDCD4 are involved in the anti-cancer effects of berberine on cell viability and apoptosis in the HCT116 cell line.

 berberine colon cancer microRNA-21 integrin β4 programmed cell death 4 Introduction

Colon cancer is a type of malignant cancer with a high rate of incidence. Its morbidity is increasing and it is ranked third among malignant types of cancer in China, with an incidence rate of 12.81% in 2010 (1). At present, the morbidity of colon cancer is increasing due to the advancement of living standards and changes in dietary structure, including increased consumption of fatty components and decreased consumption of cellulose (2).

MicroRNA (miR/miRNA)-21 has previously been demonstrated to be upregulated in various types of tumors and to control the occurrence and progression of cancer (3). Tumors occur as a result of downregulation of cancer suppressor genes and overexpression of oncogenes (3). It has been demonstrated that miR-21 is a carcinogenic miRNA and it exhibits high expression levels in solid tumors, including head and neck neoplasms, esophageal, gastric, pancreatic, lung, liver, breast and prostatic cancer, and non-solid tumors including B cell lymphoma and chronic lymphocytic leukemia (4,5).

The occurrence of colon cancer is a complex process involving multiple genes and multiple steps (6). The mutation and deficiency of tumor suppressor genes is one of the important factors resulting in cell malignancy and metastasis (7). Multiple studies have endeavored to define the use of expression profiles in determining the occurrence and progression of colon cancer (7,8). In total, >200 miRNAs have been identified from 15 paired colon cancer and para-carcinoma tissues (9). Among the 132 miRNAs which are expressed in colorectal cancer (CRC) and para-carcinoma tissues, 47 of these have been revealed to be downregulated in colon cancer (10). A previous study has demonstrated that the upregulation of miR-21 is associated with CRC (10).

Studies on berberine (Fig. 1) have revealed that it is able to treat various infectious diseases, and that it is a potential anti-cancer treatment (11,12). Berberine is a Chinese herb extract with a long history. Clinically, it is used to treat gastrointestinal diseases including enteritis and bacillary dysentery. In previous years, berberine has been revealed to possess therapeutic actions against multiple types of cancer, including osteosarcoma, prostatic and liver cancer (13–15). The present study sought to define whether berberine inhibited cell viability and induced apoptosis of the HCT116 colon cancer cell line via the regulation of miR-21-integrin β4 (ITGβ4)-programmed cell death 4 (PDCD4).

 Materials and methods <sec> <title>Cell lines and cell culture

The human CRC HCT116 cell line was purchased from Shanghai cell bank (Shanghai, China) maintained in Dulbecco's Modified Eagle's medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (Hyclone; GE Healthcare Life Sciences, Logan, UT, USA), 100 mg/ml streptomycin (Beyotime Institute of Biotechnology, Haimen, China) and 100 U/ml penicillin (Beyotime Institute of Biotechnology) at 37°C with 5% CO2 in a humidified atmosphere.

 Cellular viability assay

Human CRC HCT116 cells (1×103 cell/well) were seeded into 96-well plates and cultivated with negative control (PBS), 1, 10 or 100 µM berberine for 48 h at 37°C. MTT was added to a final concentration of 0.5 mg/ml 48 h subsequent to berberine treatment and HCT116 cells were incubated for an additional 4 h at 37°C. DMSO was then added into each well and incubated for a further 20 min. The optical density was measured at 570 nm with a microplate spectrophotometer.

 Apoptosis assay

HCT116 cells were plated in 6-well plates at a density of 5×105 cells/well and incubated with 1, 10 and 100 µM berberine for 24 h at 37°C. Flow cytometry (C6; BD Biosciences, Franklin Lakes, NJ, USA) was used to measure the apoptosis of HCT116 cells, 24 h following treatment with berberine. The relative amount of Annexin V-fluorescein isothiocyanate-positive-propidium iodide-negative cells were detected using an Apoptosis Detection kit I (BD Biosciences) and analyzed using Flowjo 7.6.1 (BD Biosciences).

 Caspase-3 activity

HCT116 cells were plated in 6-well plates at a density of 5×105 cells/well and incubated with 1, 10 and 100 µM berberine for 24 h at 37°C. Proteins were extracted from HCT116 cells or HCT116 cells transfected by miR-21 using a protein extraction reagent (RIPA; Beyotime Institute of Biotechnology, Haimen, China). The supernatant was gathered after centrifugation at 12,000 × g for 10 min at 4°C and the protein concentration was measured using a BCA Protein Assay kit (Beyotime Institute of Biotechnology). An equal amount (50 µg) of total protein was incubated with Ac-IETD-pNA (Caspase-3 activity kit; cat. no. C1116; Beyotime Institute of Biotechnology) at 37°C for 4 h. Caspase-3 activity was detected using a microplate spectrophotometer, at a wavelength of 405 nm.

 Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

HCT116 cells were plated in 6-well plates at a density of 5×105 cells/well and incubated with 1, 10 and 100 µM berberine for 24 h at 37°C. Total RNA was extracted from HCT116 cells cultured with berberine using TRIzol (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer's protocol. RNA was then reverse transcribed into cDNA using a PrimeScript RT reagent kit (Takara Biotechnology Co., Ltd., Dalian, China). QPCR assay was performed on an Applied Biosystems ABI Prism 7000 sequence detection system using QuantiTect SYBR-Green PCR kit (Qiagen China Co., Ltd., Shanghai, China). The thermocycler conditions were as follows: 95°C for 5 min, followed by 35 cycles of 95°C for 30 sec, 58°C for 30 sec and 72°C for 30 sec. The primers used for stem-loop RT-qPCR for miR-21 and U6 are presented in Table I. The relative expression levels of the gene of interest were quantified using the 2−ΔΔCq method, and U6 represented the internal control (16).

 Cell transfection

miR-21 mimics and negative control mimics sequences were as follows: 5′-UAGCUUAUCAGACUGAUGUUGA-3′ and 5′-CCCCCCCCCCCCCCCCCCCC-3′, respectively. miR-21 mimics and negative control mimics were transfected into HCT116 cells using Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol.

 Western blot analysis

HCT116 cells were plated in 6-well plates (5×105 cells/well) and incubated with 1, 10 and 100 µM berberine for 24 h at 37°C. Proteins were extracted from HCT116 cells or HCT116 cells transfected with miR-21 using a protein extraction reagent (RIPA; Beyotime Institute of Biotechnology). The supernatant was gathered after centrifugation at 12,000 × g for 10 min at 4°C to measure protein concentration using a BCA Protein Assay kit (Beyotime Institute of Biotechnology). A total of 50 µg protein per lane from each sample was separated using 10–12% SDS-PAGE (Beyotime Institute of Biotechnology) and transferred onto a polyvinylidene difluoride membrane (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The membrane was then blocked with 5% non-fat milk for 1 h at 37°C and incubated with ITGβ4 (dilution, 1:3,000; EPR8559; Abcam, Cambridge, UK), PDCD4 (dilution, 1:3,000; sc-376430; Santa Cruz Biotechnology, Inc.) and β-actin (dilution, 1:1,000; cat. no. sc-7210; Santa Cruz Biotechnology, Inc.) overnight at 4°C. The membranes were incubated with horseradish peroxidase-labeled goat anti-rabbit or anti-mouse immunoglobulin G (dilution, 1:1,000; sc-2004, sc-2005; Santa Cruz Biotechnology, Inc.) for 1 h at room temperature, and membranes were developed using an enhanced chemiluminescence kit according to the manufacturer's protocol (Beyotime Institute of Biotechnology) and quantified using sodium Image_Lab_3.0 (Bio-Rad Laboratories, Inc.).

 Statistical analysis

All statistical analyses were performed using SPSS 12.0 software (SPSS, Inc., Chicago, IL, USA). Data are presented as the mean ± standard deviation. The differences between groups were analyzed using the Student's t-test. P<0.05 was considered to indicate a statistically significant difference.

 Results <sec> <title>Berberine suppresses the viability of HCT116 cells

The results of the MTT assay demonstrated the anti-cancer effects of berberine on HCT116 cell viability. Berberine reduced the viability of HCT116 cells in a time- and dose-dependent manner (Fig. 2). Notably, treatment with 10 µM berberine significantly suppressed the cellular viability of HCT116 cells at 48 h, and treatment with 100 µM berberine also significantly suppressed the cellular viability of HCT116 cells at 24 or 48 h (Fig. 2).

 Berberine induces apoptosis and caspase-3 activity of HCT116 cells

The results from flow cytometry analysis and the Business kit demonstrated that 100 µM berberine treatment significantly increased the apoptosis rate and promoted caspase-3 activity of HCT116 cells, (Fig. 3A and B, respectively), and the effect of berberine was dose-dependent.

 Berberine suppresses miR-21 in HCT116 cells

In addition, the present study examined miR-21 expression in HCT116 cells treated with berberine using RT-qPCR. Compared with the 0 µM control group, miR-21 expression was significantly inhibited by treatment with 100 µM berberine (Fig. 4).

 Berberine induces ITGβ4 protein expression in HCT116 cells

To explore the mechanisms underlying the effect of berberine on human colon cancer, ITGβ4 protein expression was detected using western blot analysis. ITGβ4 protein expression was significantly increased in HCT116 cells treated with 100 µM berberine compared with the 0 µM berberine group (Fig. 5).

 Berberine induces PDCD4 protein expression in HCT116 cells

In order to detect the mechanisms by which berberine acts on human colon cancer, western blot analysis was used to analyze PDCD4 protein expression in HCT116 cell exposed to berberine. PDCD4 protein expression levels were significantly increased following treatment with 100 µM berberine compared with the 0 µM berberine group (Fig. 6).

 Effect of miR-21 overexpression on the berberine-induced reduction of HCT116l cell viability

The present study analyzed the association between miR-21 and the anti-cancer effect of berberine on HCT116 cell viability. Transfection with miR-21 mimics significantly increased miR-21 expression levels in HCT116 cells (Fig. 7A) and that HCT116 cell viability was increased in cells treated with miR-21 mimics and 100 µM berberine compared with the group treated with 100 µM berberine only (Fig. 7B).

 Effect of miR-21 overexpression on the effect of berberine on apoptosis and caspase-3 activity in HCT116 cells

To investigate the associations between miR-21 and the anti-cancer effects of berberine on apoptosis in HCT116 cells and HCT116 cells transfected with miR-21, the apoptosis rate and caspase-3 activity of HCT116 cells were measured using flow cytometry and caspase-3 activity kit, respectively. The rate of apoptosis and caspase-3 activity were significantly decreased in HCT116 cells treated with 100 µM berberine and miR-21 mimics, compared with the group treated with 100 µM berberine alone (Fig. 8A and B, respectively).

 Effect of miR-21 overexpression on the effect of berberine on ITGβ4 and PDCD4 protein expression levels in HCT116 cells

To investigate the association between miR-21 and the anti-cancer effects of berberine on ITGβ4 and PDCD4 protein expression in HCT116 cells, western blot analysis was performed. Overexpression of miR-21 significantly suppressed the 100 µM berberine-induced increase of ITGβ4 and PDCD4 protein expression levels in HCT116 cells, compared with the group treated with 100 µM berberine alone (Fig. 9).

 Discussion

The morbidity rate of colon cancer is high and is increasing annually, with a clear increase being observed in developed countries and developing countries (17). Among malignant tumors of the digestive tract, colon cancer ranks the fourth in terms of mortality rates in China (17). The occurrence and progression of colon cancer involves multiple-genes (18). The present study revealed that berberine significantly suppressed cell viability, induced apoptosis and increased caspase-3 activity in human colon cancer HCT116 cells. Previous studies have demonstrated that berberine inhibits cell proliferation, induces apoptosis and inhibits the invasion of human skin squamous cell carcinoma A431 cells (19), human ovarian cancer cells (20) and CRC cells (21).

miRNAs are non-coding molecules which are expressed in breast, lung, gastric, prostate, liver, colon and pancreatic cancer, spongioblastoma, pancreatic neuroendocrine tumor and cancer of the biliary duct (22). Since miRNAs frequently occur on complementary fragments, it is assumed that miRNAs have a relatively close association with the occurrence and progression of various types of cancer (8). It has previously been demonstrated that miR-21 has clinical and practical values for the diagnosis, treatment, assessment and prognosis of cancers (23).

miR-21 is involved in the processes of cell proliferation, invasion, blood vessel invasion and metastasis of multiple types of cancer (24). It has been demonstrated that miR-21 is associated with the sensitivity of anti-cancer drugs in vitro (24). Multiple signal pathways and regulatory factors are involved in influencing the sensitivity of anti-cancer drugs (25). Thus, miR-21 is deemed to be a potential therapeutic target. Antisense oligodeoxynucleotides combine with mature and carcinogenic miRNAs to inhibit tumor growth (26). miR-21 inhibitors increase the sensitivity of tumor cells to chemotherapeutic agents (25). Following treatment with berberine, miR-21 expression was significantly inhibited in human colon cancer HCT116 cells. In addition, overexpression of miR-21 significantly inhibited the anti-cancer effect of berberine on viability, apoptosis and caspase-3 activity in HCT116 cells. Hu et al (27) previously reported that berberine inhibited NF-κB and lead to a decrease in the levels of miR-21 and B cell lymphoma 2.

Integrin is a heterodimer molecule formed from two subunits, α and β (28). In total, 20 α and β types have been identified, which combine into various forms. The subunits of α and β are comprised of an extracellular region and a transmembrane domain, and the intracellular region ITGβ4 determines the specificity to physiological and pathological processes, including the inflammatory response, the immune response, proliferation, differentiation, vascularization, fertilization, embryo implantation and growth (29). The present study observed that berberine induced ITGβ4 protein expression in HCT116 cells.

There have been few previous studies investigating miR-21 in colon cancer. Studies have identified that increased expression of miR-21 downregulated expression levels of PDCD4, which is a cancer suppressor gene (5,9). PDCD4 and miR-21 have been demonstrated to be associated with gastric carcinoma, colon and breast cancer (30). The results of the present study demonstrated that berberine induced PDCD4 protein expression in HCT116 cells. Overexpression of miR-21 was observed to significantly inhibit the anti-cancer effect of berberine on ITGβ4/PDCD4 protein expression levels in HCT116 cells.

In conclusion, the present data provided evidence that berberine significantly suppressed cell viability, induced apoptosis and increased caspase-3 activity in human colon cancer HCT116 cells. The present study also demonstrated an association between miR-21 and the anti-cancer effect of berberine on the viability of colon cancer cells, which may be regulated by the miR-21-ITGβ4-PDCD4 signaling pathway. This is supported by the results of Liu et al (31), who also previously suggested that berberine sensitizes cisplatin-induced ovarian cancer cells through the miR-21/PDCD4 axis. The present study may contribute to the development of berberine for the treatment and prevention of human colon cancer.

 Acknowledgements

The present study was supported by the Natural Sciences Foundation of Shandong (grant no. ZR2011HQ049) and the Jinan Youth Science and Technology Star Plan (grant nos. 20100405 and 20090208).

 References HoltPRKozuchPMewarSColon cancer and the elderly: From screening to treatment in management of GI disease in the elderlyBest Pract Res Clin Gastroenterol23889907200910.1016/j.bpg.2009.10.01019942166 RadhakrishnanEKBavaSVNarayananSSNathLRThulasidasanAKSoniyaEVAntoRJ[6]-Gingerol induces caspase-dependent apoptosis and prevents PMA-induced proliferation in colon cancer cells by inhibiting MAPK/AP-1 signalingPLoS One9e104401201410.1371/journal.pone.010440125157570 ZhuWXuBMicroRNA-21 identified as predictor of cancer outcome: A meta-analysisPLoS One9e103373201410.1371/journal.pone.010337325098165 RibasJLupoldSEThe transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancerCell Cycle9923929201010.4161/cc.9.5.1093020160498 YoungMRSanthanamANYoshikawaNColburnNHHave tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue?Mol Interv107679201010.1124/mi.10.2.520368367 WangJDuYLiuXChoWCYangYMicroRNAs as regulator of signaling networks in metastatic colon cancerBiomed Res Int2015823620201526064956 HollisMNairKVyasAChaturvediLSGambhirSVyasDMicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivityWorld J Gastroenterol2182848292201510.3748/wjg.v21.i27.828426217080 MeloSAEstellerMDysregulation of microRNAs in cancer: Playing with fireFEBS Lett58520872099201110.1016/j.febslet.2010.08.00920708002 QiuXDongSQiaoFLuSSongYLaoYLiYZengTHuJZhangLHBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinomaOncogene3232963305201310.1038/onc.2013.15023604124 Mercado-PimentelMEOnyeaguchaBCLiQPimentelACJandovaJNelsonMAThe S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cellsFEBS Lett58923882393201510.1016/j.febslet.2015.07.01026193421 ShiGShaoJWangTWuDWangCMechanism of berberine-mediated fluconazole-susceptibility enhancement in clinical fluconazole-resistant Candida tropicalis isolatesBiomed Pharmacother93709712201710.1016/j.biopha.2017.06.10628700974 DanielBKonradBToplakMLahhamMMessenlehnerJWinklerAMacherouxPThe family of berberine bridge enzyme-like enzymes: A treasure-trove of oxidative reactionsArch Biochem Biophys63288103201710.1016/j.abb.2017.06.02328676375 LiMZhangMZhangZLLiuNHanXYLiuQCDengWJLiaoCXInduction of apoptosis by berberine in hepatocellular carcinoma HepG2 cells via downregulation of NF-κBOncol Res25233239201710.3727/096504016X1474289104907328277195 LiXZhangASunHLiuZZhangTQiuSLiuLWangXMetabolic characterization and pathway analysis of berberine protects against prostate cancerOncotarget86502265041201729029409 ZhuYMaNLiHXTianLBaYFHaoBBerberine induces apoptosis and DNA damage in MG63 human osteosarcoma cellsMol Med Rep1017341738201410.3892/mmr.2014.240525050485 LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) methodMethods25402408200110.1006/meth.2001.126211846609 HeSYJiangRFJiangJXiangYSWangLInvestigation of methylation and protein expression of the Runx3 gene in colon carcinogenesisBiomed Rep3687690201510.3892/br.2015.47926405546 LeeLDMafuraBLauscherJCSeeligerHKreisMEGröneJAntiproliferative and apoptotic effects of telmisartan in human colon cancer cellsOncol Lett826812686201410.3892/ol.2014.259225360175 LiDXZhangJZhangYZhaoPWYangLMInhibitory effect of berberine on human skin squamous cell carcinoma A431 cellsGenet Mol Res141055310568201510.4238/2015.September.8.1726400287 ChenQQinRFangYLiHBerberine sensitizes human ovarian cancer cells to cisplatin through miR-93/PTEN/Akt signaling pathwayCell Physiol Biochem36956965201510.1159/00043027026087719 LiuXJiQYeNSuiHZhouLZhuHFanZCaiJLiQBerberine inhibits invasion and metastasis of colorectal cancer cells via COX-2/PGE2 mediated JAK2/STAT3 signaling pathwayPLoS One10e0123478201510.1371/journal.pone.012347825954974 ReidGMicroRNAs in mesothelioma: From tumour suppressors and biomarkers to therapeutic targetsJ Thorac Dis710311040201526150916 PinkRCSamuelPMassaDCaleyDPBrooksSACarterDRThe passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cellsGynecol Oncol137143151201510.1016/j.ygyno.2014.12.04225579119 WangWLiJZhuWGaoCJiangRLiWHuQZhangBMicroRNA-21 and the clinical outcomes of various carcinomas: A systematic review and meta-analysisBMC Cancer14819201410.1186/1471-2407-14-81925376700 XuGZhangYWeiJJiaWGeZZhangZLiuXMicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3BMC Cancer13469201310.1186/1471-2407-13-46924112539 HeCDongXZhaiBJiangXDongDLiBJiangHXuSSunXMiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathwayOncotarget62886728881201510.18632/oncotarget.481426311740 HuHYLiKPWangXJLiuYLuZGDongRHGuoHBZhangMXSet9, NF-κB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cellsActa Pharmacol Sin34157166201310.1038/aps.2012.16123247593 LoAKYuenPWLiuYWangXHCheungALWongYCTsaoSWDownregulation of hemidesmosomal proteins in nasopharyngeal carcinoma cellsCancer Lett163117123200110.1016/S0304-3835(00)00683-211163115 FerraroAKontosCKBoniTBantounasISiakouliDKosmidouVVlassiMSpyridakisYTsiprasIZografosGPintzasAEpigenetic regulation of miR-21 in colorectal cancer: ITGβ4 as a novel miR-21 target and a three-gene network (miR-21-ITGβ4-PDCD4) as predictor of metastatic tumor potentialEpigenetics9129141201410.4161/epi.2684224149370 WangYGaoXWeiFZhangXYuJZhaoHSunQYanFYanCLiHRenXDiagnostic and prognostic value of circulating miR-21 for cancer: A systematic review and meta-analysisGene533389397201410.1016/j.gene.2013.09.03824076132 LiuSFangYShenHXuWLiHBerberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axisActa Biochim Biophys Sin (Shanghai)45756762201310.1093/abbs/gmt07523824073

Chemical structure of berberine.

Berberine suppresses HCT116 cell viability. The treatment concentrations of berberine were 0, 1, 10 and 100 µM. **P<0.01 vs. 0 µM berberine treatment group.

Berberine induces apoptosis and caspase-3 activity in HCT116 cells. Berberine induced (A) increased apoptosis and (B) increased caspase-3 activity in HCT116 cells. **P<0.01 vs. 0 µM berberine treatment group. FCM, flow cytometry.

Berberine suppresses microRNA-21 expression in HCT116 cells. **P<0.01 vs. 0 µM berberine treatment group.

Berberine induces ITGβ4 protein expression in HCT116 cells. (A) Western blot analysis demonstrated that berberine induced ITGβ4 protein expression. (B) Quantification of the western blot analysis. **P<0.01 vs. 0 µM berberine treatment group. ITGβ4, integrin β4.

Berberine induces PDCD4 protein expression in HCT116 cells. (A) Western blot analysis demonstrated that PDCD4 protein expression increased with increasing concentrations of berberine. (B) Quantification of the western blot analysis. **P<0.01 vs. 0 µM berberine treatment group. PDCD4, programmed cell death 4.

Effect of miR-21 overexpression on the berberine-induced reduction of HCT116 cell viability. (A) Effect of miR-21 mimics +100 µM berberine on miR-21 expression levels and (B) the 100 µM berberine-induced reduction in viability of HCT116 cells. The groups are as follows: Control, control group (0 µM Berberine); Berberine, 100 µM berberine treatment group; berberine + miR-21, 100 µM berberine + miR-21 mimics. **P<0.01 vs. 0 µM berberine treatment group; ##P<0.01 vs. 100 µM berberine treatment group. miR, microRNA; negative, negative control mimic.

Effect of miR-21 overexpression on the berberine-induced increase in apoptosis and caspase-3 activity in HCT116 cells. Measurements of (A) apoptosis levels and (B) caspase-3 activity in HCT116 cells. The groups are as follows: Control, control group (0 µM Berberine); Berberine, 100 µM berberine treatment group; berberine + miR-21, 100 µM berberine + miR-21 mimics. **P<0.01 vs. 0 µM berberine treatment group; ##P<0.01 vs. 100 µM berberine treatment group. miR, microRNA; FCM, flow cytometry; negative, negative conrol mimic.

Effect of miR-21 overexpression on berberine-induced alterations to ITGβ4 and PDCD4 protein expression levels in HCT116 cells. (A) Western blot analysis and (B) quantification of PDCD4 protein expression levels in HCT116 cells. The groups are as follows: Control, control group; Berberine, 100 µM berberine treatment group; berberine + miR-21, 100 µM berberine + miR-21 mimics. **P<0.01 vs. 0 µM berberine treatment group; ##P<0.01 vs. 100 µM berberine treatment group. Negative, negative control mimic.

Primers used for reverse transcription-quantitative polymerase chain reaction analysis.

Target Primer Sequence
miR-21 Forward 5′-GCGGCAACACCAGTCGATG-3′
Reverse 5′-TGCGTGTCGTGGAGTC-3′
U6 Forward 5′-GCTTCGGCAGCACATATACTAAAAT-3′
Reverse 5′-CGCTTCACGAATTTGCGTGTCAT-3′

miR, microRNA.